AMR
FDA Approves Emblaveo to Treat Certain Complicated Intraabdominal Infections
The FDA approved aztreonam-avibactam, the first and only fixed-dose, IV monobactam/beta-lactamase inhibitor ...
FEBRUARY 10, 2025
WHO Updates Priority Pathogens List of Most Threatening Drug-Resistant Bacteria
The BPPL 2024 saw the addition of four new pathogen-antibiotic combinations, but the removal of five that were ...
MAY 21, 2024
Load more